Latest news
NextCure Inc (NXTC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKeyTradingKey · Fri, 07 Aug 2026 18:20:40 GMTNextCure reports Q2 2026 net loss $14.9M, cash $20.1M as it pursues merger with Avere - TradingViewTradingView · Thu, 06 Aug 2026 20:35:16 GMTNextCure, Inc. Q2 2026: Net income $(14.9)M, EPS $(2.80) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 20:35:07 GMTNextCure (NASDAQ: NXTC) details Avere merger, $320M financing and going concern risk - Stock TitanStock Titan · Thu, 06 Aug 2026 20:26:26 GMTNextCure (Nasdaq: NXTC) details Q2 2026 loss and Avere merger - Stock TitanStock Titan · Thu, 06 Aug 2026 20:17:25 GMTNextCure - The Pharma LetterThe Pharma Letter · Wed, 05 Aug 2026 13:34:21 GMTNextCure (NXTC) details two-step Avere merger plan and upcoming Form S-4 - Stock TitanStock Titan · Tue, 04 Aug 2026 11:35:04 GMTADAR1 Capital Management reports NextCure common share purchase worth $3.59 million - BitgetBitget · Tue, 04 Aug 2026 02:52:05 GMT